ReviewJournal of neurology, neurosurgery, and psychiatry2000
Neurocysticercosis and epilepsy in developing countries.
Review in Journal of neurology, neurosurgery, and psychiatry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 4 syntheses or guidelines pooled it, 216 citations in OpenAlex.
- Neurocysticercosis control for primary epilepsy prevention: a systematic review.Pathogens and global health · 2022Pooled it
- Antiepileptic drugs for seizure control in people with neurocysticercosis.The Cochrane database of systematic reviews · 2021Pooled it
- Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.Neurology · 2013Pooled it
- A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy.PLoS neglected tropical diseases · 2010Pooled it
- Quantitative serial T2 relaxometry: a prospective evaluation in solitary cerebral cysticercosis.The neuroradiology journal · 2014Trial
- Use of oxfendazole to control porcine cysticercosis in a high-endemic area of Mozambique.PLoS neglected tropical diseases · 2012Trial
- Volumetric MRI study of the brain in patients with neurocysticercosis and mesial temporal lobe epilepsy.Epileptic disorders : international epilepsy journal with videotape · 2026Observational
- Temporal trends and future projections of cysticercosis-induced epilepsy: insights from the global burden of disease study 2021- a cross-sectional study.Frontiers in public health · 2025Article
- Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment.International journal of molecular sciences · 2024Review
- Radiology findings in neurocysticercosis: A case report.Radiology case reports · 2023Article
- Neurocysticercosis Infection: A Case Report.Cureus · 2023Article
- Challenges in the Diagnosis ofVeterinary medicine international · 2022Article
- Neurocysticercosis in Epileptic Children: An Overlooked Condition in Mozambique, Challenges in Diagnosis, Management and Research Priorities.EC microbiology · 2021Article
- Pathological Targets for Treating Temporal Lobe Epilepsy: Discoveries From Microscale to Macroscale.Frontiers in neurology · 2021Review
- Knowledge, practices and seroprevalence of Taenia species in smallholder farms in Gauteng, South Africa.PloS one · 2020Article
- Antiepileptic drugs for seizure control in people with neurocysticercosis.The Cochrane database of systematic reviews · 2019Review
- Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: a case report.BMC neurology · 2019Article
- Porcine cysticercosis in slaughtered pigs and factors related toThe Pan African medical journal · 2019Article
- Seroprevalence and awareness of porcine cysticercosis across different pig production systems in south-central Cambodia.Parasite epidemiology and control · 2018Article
- Intractable Epilepsy with Solitary Cerebral Calcification.Journal of epilepsy research · 2017Article
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurocysticercosis is a disease of poverty and underdevelopment. Little is known about the natural history of the infection in humans, but some of the mechanisms whereby the parasite remains silent and evades the host immune response are understood. Symptomatic neurocysticercosis usually results from host inflammatory response after parasite death, and the clinical manifestations can be diverse. There is no evidence that cysticidal treatment does more good than harm in addition to conventional antiepileptic treatment. Population control measures involving immunisation or mass treatment have not shown long term effectiveness.Epilepsy, similarly to neurocysticercosis, is a largely unrecognised but increasing burden on the welfare and economies of developing countries. The technology of drug treatment and psychosocial rehabilitation is well known but requires widespread and effective dissemination at low cost. There is little epidemiological data on risk factors for epilepsy in developing countries on which to base prevention strategies. The public health prioritisation of chronic disorders such as epilepsy remains a challenge for policy and practice in developing countries. For both neurocysticercosis and epilepsy, there is a dilemma about whether limited public resources would better be spent on general economic development, which would be expected to have a broad impact on the health and welfare of communities, or on specific programmes to help individual affected people with neurocysticercosis and epilepsy. Either approach requires detailed economic evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.